Zenith Drugs Current Share Price | Zenith Drugs Stock Screener
ZENITHDRUG
Pharmaceuticals
Zenith Drugs Current Stock Price Today
Track the current Zenith Drugs share price and stock price live with TickJournal's free stock screener.
Explore ZENITHDRUG dividend growth and follow the dividend payout track record.
Use the Zenith Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Zenith Drugs Market Cap
₹73.05 Cr.
ZENITHDRUG P/E Ratio (TTM)
-
Zenith Drugs P/B Ratio
1.24
EPS (TTM)
₹5.63
Dividend Yield
-
Debt to Equity
0.63
ZENITHDRUG 52 Week High
-
Zenith Drugs 52 Week Low
-
Operating Margin
-
Profit Margin
-
ZENITHDRUG Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹135.00
Total Equity
₹62.00
Zenith Drugs Current Share Price Chart
Track the current Zenith Drugs share price and stock price with an interactive chart. Analyse ZENITHDRUG price trends, trading volume, historical performance, and volatility across different timeframes — the complete Zenith Drugs stock quote in one place.
Zenith Drugs Company Profile - Fundamental Screener
Screen Zenith Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ZENITHDRUG shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0QWN01013
Zenith Drugs Balance Sheet Screener
Screen ZENITHDRUG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Assets | |||
| Total Assets | 135 | 98 | 69 |
| Current Assets | 113 | 84 | 54 |
| Fixed Assets | 11 | 12 | 11 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 9 | 9 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 62 | 18 | 12 |
| Share Capital | 17 | 0 | 0 |
| Reserves & Surplus | 45 | 17 | 12 |
Zenith Drugs Income Statement Screener - Profit & Revenue Analysis
Screen Zenith Drugs income statement and profit fundamentals.
Analyze ZENITHDRUG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Zenith Drugs share price evaluation.
| Item | None-None | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Revenue | 0 | 134 | 116 | 93 |
| Expenses | 0 | 115 | 106 | 85 |
| EBITDA | 0 | 19 | 10 | 8 |
| Operating Profit % | 0.00% | 13.00% | 8.00% | 7.00% |
| Depreciation | 0 | 1 | 1 | 1 |
| Interest | 0 | 3 | 2 | 2 |
| Profit Before Tax | 0 | 13 | 7 | 4 |
| Tax | 0 | 4 | 2 | 1 |
| Net Profit | 0 | 10 | 5 | 3 |
| EPS | 0.00 | 5.63 | 122.02 | 78.22 |
Zenith Drugs Cash Flow Screener - Liquidity Fundamentals
Screen ZENITHDRUG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March | 2022-March |
|---|---|---|---|
| Operating Activities | -13 | -5 | 5 |
| Investing Activities | 26 | 0 | -5 |
| Financing Activities | -5 | 5 | 1 |
| Net Cash Flow | 9 | 0 | 1 |
Zenith Drugs Shareholding Pattern Screener
See Zenith Drugs shareholding pattern with promoter, FII, and DII holdings.
Check Zenith Drugs promoter holding and ownership changes for ZENITHDRUG on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Sept | 2023-Sept |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 69.98% | 69.98% | 69.98% | 100.00% | 69.98% | 69.98% | 100.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.73% | 25.56% | 25.25% | 0.00% | 15.20% | 25.57% | 0.00% |
| Other Holding | 5.29% | 4.46% | 4.77% | 0.00% | 14.83% | 4.45% | 0.00% |
| Shareholder Count | 1,435 | 1,544 | 1,466 | 7 | 1,117 | 1,355 | 7 |
Zenith Drugs Share Dividend Screener - Share Yield Analysis
Check Zenith Drugs dividend history with payout and yield data.
View Zenith Drugs dividend details including ex-dates and amounts for ZENITHDRUG stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.50 | 0.70% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Zenith Drugs Stock Index Membership
See which indices include Zenith Drugs stock.
Check ZENITHDRUG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Zenith Drugs Market Events Screener - Corporate Actions
Get Zenith Drugs corporate actions including splits, bonuses, and buybacks.
Check Zenith Drugs stock events that may affect ZENITHDRUG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-23 | 2026-07-23 | Extraordinary General Meeting | NA | 5.84% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 16.69% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.67% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.76% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.06% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | 17.15% |
| 2024-09-17 | 2024-09-18 | Dividend | ₹ 0.50 /share | 107.89% |
Zenith Drugs Competitors Screener - Peer Comparison
Screen ZENITHDRUG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 455,874 | 37.16 | 61,674 | 12.69% | 11,565 | 42.22 |
| Divis Laboratories | 227,241 | 78.05 | 11,067 | 13.95% | 2,568 | 72.51 |
| Torrent Pharmaceuticals | 190,678 | 87.77 | 13,886 | 20.34% | 2,138 | 57.42 |
| Cipla | 114,876 | 34.47 | 29,045 | 2.24% | 3,870 | 41.47 |
| Zydus Life Science | 111,139 | 24.26 | 27,658 | 17.64% | 5,026 | 43.98 |
| Lupin | 101,734 | 18.33 | 29,039 | 26.75% | 5,356 | 31.49 |
| Mankind Pharma | 98,871 | 47.74 | 14,636 | 14.85% | 1,938 | 40.92 |
| Dr Reddys Laboratories | 97,656 | 30.95 | 35,059 | 3.90% | 4,158 | 41.01 |
| Laurus Labs | 97,271 | 89.91 | 6,868 | 22.01% | 890 | 62.14 |
| Aurobindo Pharma | 93,470 | 25.64 | 34,145 | 5.56% | 3,503 | 54.91 |
Zenith Drugs Company Announcements - News Screener
Screen ZENITHDRUG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.